OcellO partners in NC3R-funded collaboration with Kings College to develop 3D in vitro screening models to simulate patient derived xenograft mouse models of breast cancer. The collaboration with Prof. Andrew Tutt and Dr Rebecca Marlow, from Kings College London is valued at GBP 355,000 and will focus on the particularly aggressive ‘triple negative’ breast cancer subtype.
In the project, a panel of 3D in vitro models from tumour tissue from The KCL PDX collection will be developed and validated with standard of care therapies. These models will be added to OcellO’s portfolio of 3D tumour models and offered for fee-for-service screening.
See the link to the NC3R webstite for more details.